We’re proud to announce that Clinical Services International (CSI) has been awarded the EcoVadis Platinum Medal for the third consecutive year. This recognition places us among the top 1% of companies assessed globally for sustainability and reflects our continued commitment to responsible business practices, ethical governance, environmental stewardship, and sustainable procurement. Achieving Platinum for three years in a row is a testament to the dedication of our entire te

End-to-end comparator sourcing built for speed, control, and reliability. We exist to remove risk, reduce cost, and keep clinical trials moving. Contact us and get a response within 48 hours:

Clinical Services International (CSI)'s representatives in China are currently attending the DIA China Annual Meeting and it’s been incredibly busy so far with great conversations across the clinical trials community. If you’re attending, connect with the team to discuss global comparator sourcing, clinical trial supplies, and how CSI supports studies worldwide. Set up a meeting with the team: www.csint.com/contact-us

CSI's Managing Director Vanessa Dekou and Associate Project Manager Jessica Ianiro had a great time networking at GCSG - Global Clinical Supplies Group USA in San Diego. Schedule a consultation with CSI's team of experts: www.csint.com/contact-us

Over the past few years, GLP-1 receptor agonists have moved from a niche diabetes treatment to one of the most in-demand drug classes globally. Medicines such as semaglutide and tirzepatide are now widely used not only for type 2 diabetes but increasingly for obesity and metabolic disease. Demand Is Outpacing Supply Global demand for GLP-1 therapies has surged due to increased global trial activity involving GLP-1 comparators, expanding indications and it’s increasing availab

Cold-chain logistics play a pivotal role in pharmaceutical supply, ensuring patient safety and trial continuity. This is especially true in the oncology sector, where most therapies are temperature-sensitive and in high demand, amplifying the need for robust cold-chain infrastructure. Cold-chain logistics refers to the temperature-controlled transport and storage of pharmaceutical products. For biologics, cell and gene therapies and many oncology medications, maintaining a na

The movement of investigational medicinal products (IMPs) and comparators across borders can be a complex undertaking with customs regulations, import/export requirements, and VAT considerations. CSI supports its clients by removing this complexity and ensuring that clinical supplies move efficiently, compliantly and without delay. Global expertise, local execution Our team has extensive experience navigating country-specific regulations, documentation requirements, and impor

CSI’s colleagues in China attended Bio China this week, connecting with innovators across the biotech ecosystem and discussing how we can support efficient clinical development. Next week, the same venue will host CMAC, and our team will be there again. If you're attending, we’d love to meet and explore how CSI can support your clinical supply needs in APAC: www.csint.com/contact-us